{
    "organizations": [],
    "uuid": "415e5a84ac70621ea6cf31a30fb58cae33e87cbe",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nektar-therapeutics-reports-q1-los/brief-nektar-therapeutics-reports-q1-loss-per-share-0-60-idUSASC0A1LV",
    "ord_in_thread": 0,
    "title": "BRIEF-Nektar Therapeutics Reports Q1 Loss Per Share $0.60",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Nektar Therapeutics:\n* Q1 REVENUE $38 MILLION VERSUS I/B/E/S VIEW $35.6 MILLION * Q1 EARNINGS PER SHARE VIEW $-0.54 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-11T04:45:00.000+03:00",
    "crawled": "2018-05-11T13:02:38.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "nektar",
        "therapeutic",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}